ID
12422
Description
Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084); ODM derived from: https://clinicaltrials.gov/show/NCT02135666
Link
https://clinicaltrials.gov/show/NCT02135666
Keywords
Versions (2)
- 11/17/15 11/17/15 -
- 9/17/21 9/17/21 -
Uploaded on
November 17, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis B NCT02135666
Eligibility Hepatitis B NCT02135666
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Immunosuppressive Agents
Data type
boolean
Alias
- UMLS CUI [1]
- C0021081
- UMLS CUI [2]
- C0279021
Description
Immune-modulator therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0279021
Description
Study Subject Participation Status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
Administration of any hepatitis a and/or b vaccine
Data type
boolean
Alias
- UMLS CUI [1]
- C1170008
Description
History of hepatitis a or b
Data type
boolean
Alias
- UMLS CUI [1]
- C1875244
Description
Suspected immunosuppressive or immunologic deficiency syndromes
Data type
boolean
Alias
- UMLS CUI [1]
- C0021079
- UMLS CUI [2]
- C0021051
Description
Immunoglobulins
Data type
boolean
Alias
- UMLS CUI [1]
- C0021027
Similar models
Eligibility Hepatitis B NCT02135666
- StudyEvent: Eligibility
C0279021 (UMLS CUI [2])
C0021051 (UMLS CUI [2])